Digital Health App Tracks Pain Progress With Neurostimulation Therapy
Patients will be able to share information collected in the app with health care providers to provide a comprehensive assessment of the SCS or DRG therapy.
Miscellaneous Musculoskeletal Disorders
Most Users Report Cannabidiol Use for Treatment of Diagnosable Conditions
Psychiatric, orthopedic, and sleep issues most commonly cited in a Reddit forum
Investigational Gene Therapy Fast Tracked for Duchenne Muscular Dystrophy
PF-06939926 is a recombinant adeno-associated virus serotype 9 capsid carrying a shortened version of human dystrophin gene under the control of a human muscle-specific promoter.
Gabapentin Does Not Lower Pain Scores in Chronic Pelvic Pain
Treatment also linked to more serious adverse events.
MPR Weekly Dose Podcast Episode 50
We cover AstraZeneca’s decision to pause their COVID-19 vaccine trial; New studies indicate benefits for steroid therapy in COVID patients; Higher doses of diabetes treatment gain approval; The first non-hormonal contraceptive is launched; The FDA issues a letter regarding spinal cord stimulators; And we wrap up the latest news on drugs in the pipeline.
New Drug Product: Viltepso
This slideshow shows drug information for Viltepso. Click here for the complete Viltepso monograph.
Vitamin C Positively Linked to Skeletal Muscle Mass Measures
Positive links seen for dietary and circulating vitamin C with muscle mass in middle- and older-aged adults.
Casimersen Gets Priority Review for Duchenne Muscular Dystrophy
Casimersen is a phosphorodiamidate morpholino oligomer that works by binding to exon 45 of dystrophin pre-mRNA.
Upadacitinib Application for Ankylosing Spondylitis Submitted for Review
The application is supported by data from the multicenter, double-blind, placebo-controlled phase 2/3 SELECT-AXIS 1 study.
Viltepso Now Available for Duchenne Muscular Dystrophy
Viltepso is available through specialty distributors and specialty pharmacy providers.
